- Home
- POET vs RCKT Comparison
POET vs RCKT Comparison
Compare POET & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POET
- RCKT
- Stock Information
- Founded
- POET 1972
- RCKT 1999
- Country
- POET Canada
- RCKT United States
- Employees
- POET N/A
- RCKT N/A
- Industry
- POET Semiconductors
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- POET Technology
- RCKT Health Care
- Exchange
- POET Nasdaq
- RCKT Nasdaq
- Market Cap
- POET 366.1M
- RCKT 326.4M
- IPO Year
- POET N/A
- RCKT N/A
- Fundamental
- Price
- POET $5.77
- RCKT $2.88
- Analyst Decision
- POET Strong Buy
- RCKT Buy
- Analyst Count
- POET 2
- RCKT 13
- Target Price
- POET $6.25
- RCKT $18.50
- AVG Volume (30 Days)
- POET 1.8M
- RCKT 4.5M
- Earning Date
- POET 08-13-2025
- RCKT 08-04-2025
- Dividend Yield
- POET N/A
- RCKT N/A
- EPS Growth
- POET N/A
- RCKT N/A
- EPS
- POET N/A
- RCKT N/A
- Revenue
- POET $199,477.00
- RCKT N/A
- Revenue This Year
- POET $8,377.56
- RCKT N/A
- Revenue Next Year
- POET $1,061.73
- RCKT N/A
- P/E Ratio
- POET N/A
- RCKT N/A
- Revenue Growth
- POET N/A
- RCKT N/A
- 52 Week Low
- POET $2.27
- RCKT $2.19
- 52 Week High
- POET $7.79
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- POET 73.94
- RCKT 41.23
- Support Level
- POET $4.94
- RCKT $2.40
- Resistance Level
- POET $5.94
- RCKT $2.70
- Average True Range (ATR)
- POET 0.37
- RCKT 0.22
- MACD
- POET 0.15
- RCKT 0.13
- Stochastic Oscillator
- POET 91.75
- RCKT 60.76
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.